Steyerberg EW - Search Results

1

Substantial effective sample sizes were required for external validation studies of predictive logistic regression models.

Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Vergouwe Y, et al. Among authors: steyerberg ew. J Clin Epidemiol. 2005 May;58(5):475-83. doi: 10.1016/j.jclinepi.2004.06.017. J Clin Epidemiol. 2005. PMID: 15845334

2

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP, et al. Steyerberg EW, et al. J Clin Oncol. 1995 May;13(5):1177-87. doi: 10.1200/JCO.1995.13.5.1177. J Clin Oncol. 1995. PMID: 7537801

3

Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data.

Steyerberg EW, Kievit J, de Mol Van Otterloo JC, van Bockel JH, Eijkemans MJ, Habbema JD. Steyerberg EW, et al. Arch Intern Med. 1995 Oct 9;155(18):1998-2004. Arch Intern Med. 1995. PMID: 7575054

4

Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections.

Steyerberg EW, Keizer HJ, Stoter G, Habbema JD. Steyerberg EW, et al. Eur J Cancer. 1994;30A(9):1231-9. doi: 10.1016/0959-8049(94)90164-3. Eur J Cancer. 1994. PMID: 7999405

5

Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer.

Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Bajorin DF, Donohue JP, Habbema JD. Steyerberg EW, et al. Br J Cancer. 1996 Nov;74(9):1492-8. doi: 10.1038/bjc.1996.571. Br J Cancer. 1996. PMID: 8912551 Free PMC article.

6

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.

Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD. Steyerberg EW, et al. Cancer. 1997 Jan 15;79(2):345-55. Cancer. 1997. PMID: 9010108

7

Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.

Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt Koops H, Fosså SD, Keizer HJ. Steyerberg EW, et al. J Urol. 1997 Aug;158(2):474-8. doi: 10.1016/s0022-5347(01)64506-3. J Urol. 1997. PMID: 9224327 Review.

8

Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.

Steyerberg EW, Gerl A, Fossá SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ. Steyerberg EW, et al. J Clin Oncol. 1998 Jan;16(1):269-74. doi: 10.1200/JCO.1998.16.1.269. J Clin Oncol. 1998. PMID: 9440752

9

Use of Markov series and Monte Carlo simulation in predicting replacement valve performances.

de Kruyk AR, van der Meulen JH, van Herwerden LA, Bekkers JA, Steyerberg EW, Dekker R, Habbema JD. de Kruyk AR, et al. Among authors: steyerberg ew. J Heart Valve Dis. 1998 Jan;7(1):4-12. J Heart Valve Dis. 1998. PMID: 9502132

10

Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis.

Steyerberg EW, Marshall PB, Keizer HJ, Habbema JD. Steyerberg EW, et al. Cancer. 1999 Mar 15;85(6):1331-41. Cancer. 1999. PMID: 10189139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results